Insider · CIK 0002130205
David Allen Stamler
Files at ATHE (ALTERITY THERAPEUTICS LTD). First filing -, latest -.
In brief
David Allen Stamler files SEC Form 4 as CEO and director at ATHE (ALTERITY THERAPEUTICS LTD). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David Allen Stamler has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | ATHE ALTERITY THERAPEUTICS LTD | POpen-market purchase Listed option exp 31 Aug 2026derivative | -47,620 | $0.50 | $24k | 0 | 36 d ago |
Questions about David Allen Stamler
Answered from the filings on this page, as of the latest one.
Is David Allen Stamler buying or selling?
David Allen Stamler has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David Allen Stamler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Allen Stamler has 0.
Where does David Allen Stamler file Form 4?
David Allen Stamler has filed Form 4 at ATHE (ALTERITY THERAPEUTICS LTD) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.